Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 8Phase 1/2 3Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 5Sarcoma 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Gliosarcoma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

fluorodopa F 18 1Utrogestan 1Triiodothyronine 1Temozolomide 1Radiotherapy 1Radiosurgery 1Radiation 1Progestins 1Progesterone 1Perfusion Magnetic Resonance Imaging 1Molecular Targeted Therapy 1Methimazole 1Magnetic Resonance Spectroscopy 1Lomustine 1Irinotecan 1Gadolinium DTPA 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Biopsy 1Bevacizumab 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Gliosarcoma × Irinotecan × Clear all
NCT01086345 2018-07-03

Radiosurgery Plus Bevacizumab in Glioblastoma

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡